Hearing Technologies

Featured image for “Signia MaX Hearing Aids Now Available Through VA, DoD, and IHS”
Nov. 02, 2026

Signia MaX Hearing Aids Now Available Through VA, DoD, and IHS

HHTM
ISELIN, NEW JERSEY — Signia has announced that its Pure Charge&Go MaX hearing aids are now available through the U.S. Department of Veterans Affairs (VA), Department of Defense (DoD), and Indian Health Service (IHS), expanding access to the company’s latest artificial intelligence-based hearing technology. The announcement follows the August introduction of Signia’s Multi-adaptive Xperience (MaX) platform, which incorporates four specialized
Featured image for “Phonak Brings EON Hearing Aid Portfolio to Veterans and Active-Duty Military”
Nov. 02, 2026

Phonak Brings EON Hearing Aid Portfolio to Veterans and Active-Duty Military

HHTM
STÄFA, SWITZERLAND — Phonak has announced that its EON hearing aid portfolio is now available through the U.S. Department of Veterans Affairs (VA) and Department of Defense (DOD), expanding access to the company’s latest hearing technology for eligible veterans and active-duty military personnel. The EON platform incorporates Phonak’s newest artificial intelligence-based sound processing technology, including Spheric Speech Clarity 3.0 and
Featured image for “GN Expands VA Hearing Aid Options with ReSound Sensia and Bimodal Solutions”
Nov. 02, 2026

GN Expands VA Hearing Aid Options with ReSound Sensia and Bimodal Solutions

HHTM
SHAKOPEE, MINNESOTA — GN has announced that its ReSound Sensia hearing aid portfolio is now available to eligible U.S. veterans through Department of Veterans Affairs (VA) audiology clinics and participating care facilities nationwide, expanding access to the company’s latest artificial intelligence-based hearing technology. Originally introduced in the United States in August 2026, ReSound Sensia incorporates GN’s new AI processing platform, designed
Featured image for “Oticon Expands VA Hearing Aid Portfolio with Reveal and CROS RE”
Nov. 02, 2026

Oticon Expands VA Hearing Aid Portfolio with Reveal and CROS RE

HHTM
SOMERSET, NEW JERSEY — Oticon has announced that its Reveal hearing aids are now available through the U.S. Department of Veterans Affairs (VA) contract, expanding access to the company’s latest hearing technology for eligible veterans. The announcement also highlights additional products in Oticon’s VA portfolio, including CROS RE, Verit, Play SI pediatric hearing aids, and the company’s Zeal in-the-ear hearing
Featured image for “Gene Therapy and Light-Based Cochlear Implants Show Promise for Hearing Restoration”
Oct. 25, 2026

Gene Therapy and Light-Based Cochlear Implants Show Promise for Hearing Restoration

HHTM
Researchers have demonstrated that experimental light-based cochlear implants can activate auditory neurons with greater frequency selectivity than conventional electrical stimulation, potentially advancing the development of more precise hearing restoration technologies. The findings, published October 22, 2026, in EMBO Molecular Medicine, come from a preclinical study using Mongolian gerbils. The research combined a light-sensitive protein with experimental optical cochlear implants containing
Featured image for “Bang & Olufsen Joins €2.9 Million Fund Backing Sound Technology Startups”
Oct. 21, 2026

Bang & Olufsen Joins €2.9 Million Fund Backing Sound Technology Startups

HHTM
STRUER, DENMARK — SoundInvest, the investment company affiliated with Sound Hub Denmark, has announced the first close of its second venture fund, securing €2.9 million (approximately DKK 21 million) in commitments to support early-stage companies developing technologies involving sound, acoustics, and hearing. The new fund, SoundInvest Fund II, includes investments from existing backers Færchfonden and Vald. Birn Holding, alongside new investor
Featured image for “Cochlear’s Nucleus Nexa System Earns Spot on TIME’s 2026 Best Inventions List”
Oct. 21, 2026

Cochlear’s Nucleus Nexa System Earns Spot on TIME’s 2026 Best Inventions List

HHTM
LONE TREE, COLORADO — Cochlear Limited announced that its Cochlear Nucleus Nexa System has been named one of TIME’s Best Inventions of 2026, recognizing the cochlear implant platform’s ability to support future technology updates within the implanted device itself. The recognition follows the system’s introduction in 2025, when Cochlear unveiled a new implant architecture designed to extend the potential for
Featured image for “Phonak Launches AI-Powered Roger On Sphere for Hearing Aid and Cochlear Implant Users”
Oct. 14, 2026

Phonak Launches AI-Powered Roger On Sphere for Hearing Aid and Cochlear Implant Users

HHTM
STÄFA, SWITZERLAND – Phonak has announced the launch of Roger On Sphere™, a new wireless remote microphone that incorporates deep neural network (DNN) technology to separate speech from background noise in real time. The device brings AI-based speech enhancement to the company’s established Roger microphone platform, with the goal of improving communication in challenging listening environments where hearing aids alone may
Featured image for “Widex Announces U.S. and European Availability of Allure AI Hearing Aids”
Oct. 14, 2026

Widex Announces U.S. and European Availability of Allure AI Hearing Aids

HHTM
LYNGE, DENMARK – Widex, part of WSA, has announced the expansion of its Allure AI RIC hearing aids with Clarity Boost into 15 additional countries, including the United States and major European markets. The expansion brings the company’s dual-processor hearing technology, which combines natural sound processing with user-activated AI noise reduction, to a broader international audience. Alongside the market expansion, Widex
Featured image for “Auditdata Adds NAL-NL3 and Oldenburg Matrix Test to Measure Clinical Platform”
Oct. 07, 2026

Auditdata Adds NAL-NL3 and Oldenburg Matrix Test to Measure Clinical Platform

HHTM
COPENHAGEN, DENMARK — Auditdata has added two independent hearing-care tools to its Measure™ clinical software platform, bringing the new NAL-NL3 hearing aid fitting system and the Oldenburg Matrix Sentence Test into a single clinical workflow. The additions connect two important parts of hearing care: selecting evidence-based hearing aid fitting targets and evaluating how well a patient can understand speech in